David J. Hassemer

908 total citations
26 papers, 688 citations indexed

About

David J. Hassemer is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Biochemistry. According to data from OpenAlex, David J. Hassemer has authored 26 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Biochemistry. Recurrent topics in David J. Hassemer's work include Clinical Laboratory Practices and Quality Control (10 papers), Cystic Fibrosis Research Advances (7 papers) and Neonatal Respiratory Health Research (7 papers). David J. Hassemer is often cited by papers focused on Clinical Laboratory Practices and Quality Control (10 papers), Cystic Fibrosis Research Advances (7 papers) and Neonatal Respiratory Health Research (7 papers). David J. Hassemer collaborates with scholars based in United States, Netherlands and Belgium. David J. Hassemer's co-authors include Ronald H. Laessig, Philip M. Farrell, Elaine H. Mischler, Ronald G. Gregg, Anita Laxova, W. Theodore Bruns, Michael J. Rock, Benjamin S. Wilfond, Gary Hoffman and Lee‐Jen Wei and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Chemistry.

In The Last Decade

David J. Hassemer

26 papers receiving 656 citations

Peers

Countries citing papers authored by David J. Hassemer

Since Specialization

Citations

This map shows the geographic impact of David J. Hassemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Hassemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Hassemer more than expected).

Fields of papers citing papers by David J. Hassemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Hassemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Hassemer. The network helps show where David J. Hassemer may publish in the future.

Co-authorship network of co-authors of David J. Hassemer

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Hassemer. A scholar is included among the top collaborators of David J. Hassemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Hassemer. David J. Hassemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interlaboratory surveys to assess performance: more than proficiency testing. 2006 ·PubMed ·David J. Hassemer	2
2	Wisconsin State Laboratory of Hygiene's role in clinical laboratory improvement. 2003 ·PubMed ·David J. Hassemer	8
3	Newborn Screening for Cystic Fibrosis in Wisconsin: Comparison of Biochemical and Molecular Methods 1997 ·PEDIATRICS ·Ronald G. Gregg, (unknown), Philip M. Farrell, Rebecca E. Koscik, Michael R. Kosorok, Anita Laxova, Ronald H. Laessig, Gary Hoffman, David J. Hassemer, Elaine H. Mischler, Mark Splaingard	104
4	Limitations of Proficiency Testing Under CLIA '67 1992 ·Clinical Chemistry ·Ronald H. Laessig, Sharon S. Ehrmeyer, (unknown), (unknown), David J. Hassemer	7
5	Review of Actual Proficiency-Testing Performance Under CLIA '67 (March 14, 1990) Rules: Perspective from the First Year's Data 1992 ·Clinical Chemistry ·(unknown), (unknown), Sharon S. Ehrmeyer, Ronald H. Laessig, David J. Hassemer	2
6	Comparison of Plastic vs. Glass Evacuated Serum-Separator (SSTTM) Blood-Drawing Tubes for Common Clinical Chemistry Determinations 1992 ·Clinical Chemistry ·Barbara M. Hill, Ronald H. Laessig, David D. Koch, David J. Hassemer	26
7	Performance of the Kodak DT-60 physician's office analyzer as measured by CLIA-88 proposed evaluation criteria. Assessment of demographic and quality assurance factors influencing performance. 1992 ·PubMed ·Sandra Meier, Sharon S. Ehrmeyer, Ronald H. Laessig, (unknown), (unknown), David J. Hassemer	2
8	Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin 1991 ·Pediatric Pulmonology ·David J. Hassemer, Ronald H. Laessig, Gary Hoffman, Philip M. Farrell	9
9	Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery 1991 ·Pediatric Pulmonology ·Philip M. Farrell, Elaine H. Mischler, Norman Fost, Benjamin S. Wilfond, Audrey Tluczek, Ronald G. Gregg, W. Theodore Bruns, David J. Hassemer, Ronald H. Laessig	22
10	Newborn Screening for Cystic Fibrosis Is Complicated by Age-Related Decline in Immunoreactive Trypsinogen Levels 1990 ·PEDIATRICS ·Michael J. Rock, Elaine H. Mischler, Philip M. Farrell, Lee‐Jen Wei, W. Theodore Bruns, David J. Hassemer, Ronald H. Laessig	82
11	Immunoreactive trypsinogen screening for cystic fibrosis: Characterization of infants with a false‐positive screening test 1989 ·Pediatric Pulmonology ·Michael J. Rock, Elaine H. Mischler, Philip M. Farrell, W. Theodore Bruns, David J. Hassemer, Ronald H. Laessig	62
12	Neonatal screening for cystic fibrosis in Wisconsin. 1989 ·PubMed ·Elaine H. Mischler, Philip M. Farrell, Tony Bruns, (unknown), Audrey Tluczek, Holly Colby, Catherine McCarthy, David J. Hassemer, Ronald H. Laessig, Norman Fost	13
13	Quality Control and Quality Assurance 1986 ·Clinics in Laboratory Medicine ·Ronald H. Laessig, Sharon S. Ehrmeyer, David J. Hassemer	15
14	Dual-channel continuous-flow system for determination of phenylalanine and galactose: application to newborn screening. 1984 ·Clinical Chemistry ·Gary Hoffman, Ronald H. Laessig, David J. Hassemer, (unknown)	13
15	A Comparison of Hard and Soft Glass Blood-drawing Tubes 1979 ·American Journal of Clinical Pathology ·Ronald H. Laessig, David J. Hassemer, Gary Hoffman, James O. Westgard, R. Neill Carey, Donald H. Feldbruegge	2
16	Changes in Serum Chemical Values as a Result of Prolonged Contact with the Clot 1976 ·American Journal of Clinical Pathology ·Ronald H. Laessig, (unknown), David J. Hassemer, (unknown), (unknown)	29
17	Assessment of the Serum Separator Tube as an Intermediate Storage Device with in the Laboratory 1976 ·American Journal of Clinical Pathology ·Ronald H. Laessig, David J. Hassemer, James O. Westgard, R. Neill Carey, Donald H. Feldbruegge, (unknown)	6
18	Assessment of a serum separator device for obtaining serum specimens suitable for clinical analyses. 1976 ·Clinical Chemistry ·Ronald H. Laessig, James O. Westgard, R. Neill Carey, David J. Hassemer, (unknown), Donald H. Feldbruegge	10
19	The Effects of 0.1 and 1.0 PerCent Erythrocytes and Hemolysis on Serum Chemistry Values 1976 ·American Journal of Clinical Pathology ·Ronald H. Laessig, David J. Hassemer, (unknown), (unknown)	34
20	Reactions of sodium pentacyanonitrosylferrate(II) with some thioureas in methanol solution 1970 ·Journal of Inorganic and Nuclear Chemistry ·D.X. West, David J. Hassemer	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact